reference

[Guest guest]

Serrapeptase Reference

l.. Kee WH. Tan SL, Lee V. Salmon YM. The treatment of breast engorgement with

Serrapeptase (Danzen): a random ized double-blind controlled trial. Singapore

Med J. 1989:30(1):48-54.

2. M izukoshi, D. et al. A double-blind clinical study of serrapeptase in the

treatment of chronic sinusitis. Igaku Ayrni 109:50-62.1979.

3. Carratu, L. et al. Physio-chemical and rheological research on mucolytic

activity of serrapeptase in chronic broncho-pneumopathies. Curr. Ther. Res.

28(6):937-951. 1980.

4. Braga, P.C. et al. Effects of serrapeptase on muco-ciliary clearance in

patients with chronic bronchitis. Curr. Ther. Res. 29(5):738-744,1981.

5. Mazzonie, A. et al. Evaluation of serrapeptase in acute or chronic

inflammation of otorhinolaryngology pathology: a multicentre, double-blind

randomized trial versus placebo. J. int. Med. Res. 18(5):379-388,1990.

6. Kakinumu, A. et al. Regression of fibrinolysis in scalded rats by

administration of serrapeptase. Biochem. Pharmacol. 31:2861-2866,1982.

7. Marly, M. Enzymotherapie anti-inflammatoire a l'aide de la serrapeptase:

resultats cliniques en traumatologie et en ORL. C RTherapeut. 3:9-19,1985.

8. Odagiri, J. et al. Clinical applications of serrapeptase in sinusitis. Med.

Consult. New Remedy 6:201-209, 1979.

9. Yamazaki, J. et al. Anti-inflammatory activity of TSP, a protease produced by

a strain of Serratia. Folia Pharmacol. Japon. 6^302-314,1967.

I0. Harad~, Y. Clinical efficacy of serrapeptase on buccal swelling after

radical operation for chronic sinusitis. Igaku Ayumi 123:768-778.1982.

1 I. Matsudo, A. et at. Effect of serrapeptase (Danzen) on inflammatory edema

following operation for thyropid disease. Med. Consult. New Remedy 18:171-175,

1981.

12. Fujitani, T. et al. Effect of anti-inflammatory agent on transfer of

antibiotics to the maxillary sinus mucosa in chronic sinusitis.

Otorhinolaryngol. Clin. North Am. 66:557-565. 1976.

13. Tago. T. and Mitsui, S. Effects of serrapeptase in dissolution of sputum,

especially in patients with bronchial asthma. Jap. Clin. Exp. Med. 49:222-228,

1972.

14. Mazzonie, A. et al. Evaluation of serrapeptase in acute or chronic

inflammation of otorhinolaryngology pathology: a multicentre, double-blind

randomized trial versus placebo. J. int. Med. Res. 18(5):379-388,1990.

15. Kase, Y. et al. A new method for evaluating mucolytic expectorant activity

and its application. II. Application to two proteolytic enzymes, serrapeptase

and seaprose. Arzneimittelforschung 32:374-378,1982.

16. Marriott, C. Modification of the rheoloaical properties of mucus by drugs.

Adv. Exp. Med. Biol. 144^75-84, 1982.

17. Majima. Y. et al. Effects of orally administered drugs on dynamic

viscoelasticity of human nasal mucus. Am. Rev. Respit. Dis. 141:79-83.1990.

18. Miyata, K. Intestinal absorption of serrapeptase. J ApplBiochem.

1980:2:111-16.

19. Aso T. et al. Breast engorgement and its treatment: Clinical effects of

Danzen (serrapeptase) an anti-inflammatory enzyme preparation. The world of

Obstetrics and Gynecology (Japanese). 1981:33:371-9.

20. Esch PM, Gemgross H. Fabian A. Reduction of postoperative swelling.

Objective measurement of swelling of the upper ankle joint in treatment with

serrapeptase-a prospective study (German). FortschrMed. 1989; 107(4):67-8, 71-2.

21. Majima Y, lnagaki M, Hirata K. Takeuchi K, M orishita A, Sakakura Y. The

effect of an orally administered proteolytic enzyme on the elasticity and

viscosity of nasal mucus. Arch Otorhinolaryngol. 1988;244(6):355-9.

22. Selan L, Berlutti F, Passariello C. Comodi-Ballanti MR, Thaller MC.

?roteolytic enzymes: a new treatment strategy for prosthetic infections?

Antimicrob Agents Cheroother. 1993; 37(12):2618-21.

23. Koyama A, Mori J, Tokuda H, Waku M, Anno H, Katayama T, Murakami K, Komatsu

H, Hirata M, Arai T, et al. Augmentation by serrapeptase of tissue permeation by

cefotiam (Japanese). Jpn JAntibiot. 1986; 39(3):761-7

for more information visit: www.serrapeptase.info

© Naturally Healthy Publications

[Guest guest]

You will find all the information in the registration form and it guidance document. Read it through.:)From: a.bhaidkar <draniruddhaashok@...> Sent: Thu, 24 March, 2011 10:02:06Subject: reference

I have secured a 7.5 in IELTS and I am now looking forward to rggister with the GDC for the ORE.

I understand that for that we require two references (?from a gdc registered doc in uk)

is that so..

can you advise abt the procedure